サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1121115

世界の肝臓がん治療薬市場：考察と予測 (2028年まで)

Global Liver Cancer Therapeutics Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 112 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の肝臓がん治療薬市場：考察と予測 (2028年まで)
出版日: 2022年09月01日
発行: QYResearch
ページ情報: 英文 112 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、肝臓がん治療薬 (Liver Cancer Therapeutics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の肝臓がん治療薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Targeted Therapy
    • Radiation Therapy
    • Immunotherapy
    • Chemotherapy
    • Other
  • 市場：アプリケーション別
    • 世界の肝臓がん治療薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hepatocellular Carcinoma
    • Cholangio Carcinoma
    • Hepatoblastoma
    • Other
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の肝臓がん治療薬の市場展望 (2017-2028)
  • 肝臓がん治療薬の市場成長トレンド：地域別
    • 肝臓がん治療薬 市場規模：地域別: 2017 VS 2021 VS 2028
    • 肝臓がん治療薬の市場規模実績：地域別 (2017-2022)
    • 肝臓がん治療薬の市場規模予測：地域別 (2023-2028)
  • 肝臓がん治療薬 市場動向
    • 肝臓がん治療薬 業界動向
    • 肝臓がん治療薬 市場の促進要因
    • 肝臓がん治療薬 市場の課題
    • 肝臓がん治療薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の肝臓がん治療薬の上位企業：収益別
    • 世界の肝臓がん治療薬の上位企業：収益別 (2017-2022)
    • 世界の肝臓がん治療薬の収益シェア：企業別 (2017-2022)
  • 世界の肝臓がん治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：肝臓がん治療薬の収益
  • 世界の肝臓がん治療薬 市場集中度
    • 世界の肝臓がん治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 肝臓がん治療薬の収益 2021
  • 肝臓がん治療薬の主要企業の本社および事業エリア
  • 主要企業 肝臓がん治療薬の製品ソリューションおよびサービス
  • 市場参入時期： 肝臓がん治療薬 市場
  • M&A, 拡張計画

第4章 肝臓がん治療薬 内訳データ：タイプ別

  • 世界の肝臓がん治療薬の市場規模実績：タイプ別 (2017-2022)
  • 世界の肝臓がん治療薬の市場規模予測：タイプ別 (2023-2028)

第5章 肝臓がん治療薬 内訳データ：アプリケーション別

  • 世界の肝臓がん治療薬の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の肝臓がん治療薬の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の肝臓がん治療薬 市場規模 (2017-2028)
  • 北米の肝臓がん治療薬 市場規模：タイプ別
    • 北米の肝臓がん治療薬 市場規模：タイプ別 (2017-2022)
    • 北米の肝臓がん治療薬 市場規模：タイプ別 (2023-2028)
    • 北米の肝臓がん治療薬の市場シェア：タイプ別 (2017-2028)
  • 北米の肝臓がん治療薬 市場規模：アプリケーション別
    • 北米の肝臓がん治療薬 市場規模：アプリケーション別 (2017-2022)
    • 北米の肝臓がん治療薬 市場規模：アプリケーション別 (2023-2028)
    • 北米の肝臓がん治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 北米の肝臓がん治療薬 市場規模：国別
    • 北米の肝臓がん治療薬 市場規模：国別 (2017-2022)
    • 北米の肝臓がん治療薬 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の肝臓がん治療薬 市場規模 (2017-2028)
  • 欧州の肝臓がん治療薬 市場規模：タイプ別
    • 欧州の肝臓がん治療薬 市場規模：タイプ別 (2017-2022)
    • 欧州の肝臓がん治療薬 市場規模：タイプ別 (2023-2028)
    • 欧州の肝臓がん治療薬の市場シェア：タイプ別 (2017-2028)
  • 欧州の肝臓がん治療薬 市場規模：アプリケーション別
    • 欧州の肝臓がん治療薬 市場規模：アプリケーション別 (2017-2022)
    • 欧州の肝臓がん治療薬 市場規模：アプリケーション別 (2023-2028)
    • 欧州の肝臓がん治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の肝臓がん治療薬 市場規模：国別
    • 欧州の肝臓がん治療薬 市場規模：国別 (2017-2022)
    • 欧州の肝臓がん治療薬 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 肝臓がん治療薬 市場規模 (2017-2028)
  • アジア太平洋地域 肝臓がん治療薬 市場規模：タイプ別
    • アジア太平洋地域 肝臓がん治療薬 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 肝臓がん治療薬 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 肝臓がん治療薬の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 肝臓がん治療薬 市場規模：アプリケーション別
    • アジア太平洋地域 肝臓がん治療薬 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 肝臓がん治療薬 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 肝臓がん治療薬の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 肝臓がん治療薬 市場規模：地域別
    • アジア太平洋地域 肝臓がん治療薬 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 肝臓がん治療薬 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの肝臓がん治療薬 市場規模 (2017-2028)
  • ラテンアメリカの肝臓がん治療薬 市場規模：タイプ別
    • ラテンアメリカの肝臓がん治療薬 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの肝臓がん治療薬 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの肝臓がん治療薬の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの肝臓がん治療薬 市場規模：アプリケーション別
    • ラテンアメリカの肝臓がん治療薬 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの肝臓がん治療薬 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの肝臓がん治療薬の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの肝臓がん治療薬 市場規模：国別
    • ラテンアメリカの肝臓がん治療薬 市場規模：国別 (2017-2022)
    • ラテンアメリカの肝臓がん治療薬 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの肝臓がん治療薬 市場規模 (2017-2028)
  • 中東・アフリカの肝臓がん治療薬 市場規模：タイプ別
    • 中東・アフリカの肝臓がん治療薬 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの肝臓がん治療薬 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの肝臓がん治療薬の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの肝臓がん治療薬 市場規模：アプリケーション別
    • 中東・アフリカの肝臓がん治療薬 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの肝臓がん治療薬 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの肝臓がん治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの肝臓がん治療薬 市場規模：国別
    • 中東・アフリカの肝臓がん治療薬 市場規模：国別 (2017-2022)
    • 中東・アフリカの肝臓がん治療薬 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • ArQule
  • Bayer
  • Bristol-Myers Squibb
  • Celsion
  • Eisai
  • Exelixis
  • Roche
  • Merck
  • Pfizer
  • IntegraGen

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Liver Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Targeted Therapy
  • Table 3. Key Players of Radiation Therapy
  • Table 4. Key Players of Immunotherapy
  • Table 5. Key Players of Chemotherapy
  • Table 6. Key Players of Other
  • Table 7. Global Liver Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 8. Global Liver Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 9. Global Liver Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 10. Global Liver Cancer Therapeutics Market Share by Region (2017-2022)
  • Table 11. Global Liver Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 12. Global Liver Cancer Therapeutics Market Share by Region (2023-2028)
  • Table 13. Liver Cancer Therapeutics Market Trends
  • Table 14. Liver Cancer Therapeutics Market Drivers
  • Table 15. Liver Cancer Therapeutics Market Challenges
  • Table 16. Liver Cancer Therapeutics Market Restraints
  • Table 17. Global Liver Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
  • Table 18. Global Liver Cancer Therapeutics Revenue Share by Players (2017-2022)
  • Table 19. Global Top Liver Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2021)
  • Table 20. Ranking of Global Top Liver Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
  • Table 21. Global 5 Largest Players Market Share by Liver Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Liver Cancer Therapeutics Product Solution and Service
  • Table 24. Date of Enter into Liver Cancer Therapeutics Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Liver Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 27. Global Liver Cancer Therapeutics Revenue Market Share by Type (2017-2022)
  • Table 28. Global Liver Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 29. Global Liver Cancer Therapeutics Revenue Market Share by Type (2023-2028)
  • Table 30. Global Liver Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 31. Global Liver Cancer Therapeutics Revenue Share by Application (2017-2022)
  • Table 32. Global Liver Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 33. Global Liver Cancer Therapeutics Revenue Share by Application (2023-2028)
  • Table 34. North America Liver Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 35. North America Liver Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 36. North America Liver Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 37. North America Liver Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 38. North America Liver Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 39. North America Liver Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 40. Europe Liver Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 41. Europe Liver Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 42. Europe Liver Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 43. Europe Liver Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 44. Europe Liver Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 45. Europe Liver Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Liver Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Liver Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Liver Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Liver Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific Liver Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific Liver Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
  • Table 52. Latin America Liver Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 53. Latin America Liver Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 54. Latin America Liver Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 55. Latin America Liver Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 56. Latin America Liver Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 57. Latin America Liver Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Liver Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Liver Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Liver Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Liver Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa Liver Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa Liver Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 64. ArQule Company Details
  • Table 65. ArQule Business Overview
  • Table 66. ArQule Liver Cancer Therapeutics Product
  • Table 67. ArQule Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 68. ArQule Recent Developments
  • Table 69. Bayer Company Details
  • Table 70. Bayer Business Overview
  • Table 71. Bayer Liver Cancer Therapeutics Product
  • Table 72. Bayer Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 73. Bayer Recent Developments
  • Table 74. Bristol-Myers Squibb Company Details
  • Table 75. Bristol-Myers Squibb Business Overview
  • Table 76. Bristol-Myers Squibb Liver Cancer Therapeutics Product
  • Table 77. Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 78. Bristol-Myers Squibb Recent Developments
  • Table 79. Celsion Company Details
  • Table 80. Celsion Business Overview
  • Table 81. Celsion Liver Cancer Therapeutics Product
  • Table 82. Celsion Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 83. Celsion Recent Developments
  • Table 84. Eisai Company Details
  • Table 85. Eisai Business Overview
  • Table 86. Eisai Liver Cancer Therapeutics Product
  • Table 87. Eisai Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 88. Eisai Recent Developments
  • Table 89. Exelixis Company Details
  • Table 90. Exelixis Business Overview
  • Table 91. Exelixis Liver Cancer Therapeutics Product
  • Table 92. Exelixis Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 93. Exelixis Recent Developments
  • Table 94. Roche Company Details
  • Table 95. Roche Business Overview
  • Table 96. Roche Liver Cancer Therapeutics Product
  • Table 97. Roche Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 98. Roche Recent Developments
  • Table 99. Merck Company Details
  • Table 100. Merck Business Overview
  • Table 101. Merck Liver Cancer Therapeutics Product
  • Table 102. Merck Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 103. Merck Recent Developments
  • Table 104. Pfizer Company Details
  • Table 105. Pfizer Business Overview
  • Table 106. Pfizer Liver Cancer Therapeutics Product
  • Table 107. Pfizer Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 108. Pfizer Recent Developments
  • Table 109. IntegraGen Company Details
  • Table 110. IntegraGen Business Overview
  • Table 111. IntegraGen Liver Cancer Therapeutics Product
  • Table 112. IntegraGen Revenue in Liver Cancer Therapeutics Business (2017-2022) & (US$ Million)
  • Table 113. IntegraGen Recent Developments
  • Table 114. Research Programs/Design for This Report
  • Table 115. Key Data Information from Secondary Sources
  • Table 116. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Liver Cancer Therapeutics Market Share by Type: 2021 VS 2028
  • Figure 2. Targeted Therapy Features
  • Figure 3. Radiation Therapy Features
  • Figure 4. Immunotherapy Features
  • Figure 5. Chemotherapy Features
  • Figure 6. Other Features
  • Figure 7. Global Liver Cancer Therapeutics Market Share by Application: 2021 VS 2028
  • Figure 8. Hepatocellular Carcinoma Case Studies
  • Figure 9. Cholangio Carcinoma Case Studies
  • Figure 10. Hepatoblastoma Case Studies
  • Figure 11. Other Case Studies
  • Figure 12. Liver Cancer Therapeutics Report Years Considered
  • Figure 13. Global Liver Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 14. Global Liver Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 15. Global Liver Cancer Therapeutics Market Share by Region: 2021 VS 2028
  • Figure 16. Global Liver Cancer Therapeutics Market Share by Players in 2021
  • Figure 17. Global Top Liver Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2021)
  • Figure 18. The Top 10 and 5 Players Market Share by Liver Cancer Therapeutics Revenue in 2021
  • Figure 19. North America Liver Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 20. North America Liver Cancer Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 21. North America Liver Cancer Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 22. North America Liver Cancer Therapeutics Market Size Share by Country (2017-2028)
  • Figure 23. United States Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Canada Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe Liver Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 26. Europe Liver Cancer Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 27. Europe Liver Cancer Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 28. Europe Liver Cancer Therapeutics Market Size Share by Country (2017-2028)
  • Figure 29. Germany Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. France Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. U.K. Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Italy Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Russia Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Nordic Countries Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific Liver Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 36. Asia Pacific Liver Cancer Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 37. Asia Pacific Liver Cancer Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 38. Asia Pacific Liver Cancer Therapeutics Market Size Share by Region (2017-2028)
  • Figure 39. China Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Japan Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. South Korea Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Southeast Asia Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. India Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Australia Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 45. Latin America Liver Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 46. Latin America Liver Cancer Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 47. Latin America Liver Cancer Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 48. Latin America Liver Cancer Therapeutics Market Size Share by Country (2017-2028)
  • Figure 49. Mexico Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Brazil Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Middle East & Africa Liver Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 52. Middle East and Africa Liver Cancer Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 53. Middle East and Africa Liver Cancer Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 54. Middle East and Africa Liver Cancer Therapeutics Market Size Share by Country (2017-2028)
  • Figure 55. Turkey Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Saudi Arabia Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. UAE Liver Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. ArQule Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 59. Bayer Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 61. Celsion Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 62. Eisai Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 63. Exelixis Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 64. Roche Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 65. Merck Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 66. Pfizer Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 67. IntegraGen Revenue Growth Rate in Liver Cancer Therapeutics Business (2017-2022)
  • Figure 68. Bottom-up and Top-down Approaches for This Report
  • Figure 69. Data Triangulation
  • Figure 70. Key Executives Interviewed
目次

This research report focuses on the Liver Cancer Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Targeted Therapy
    • 1.2.3 Radiation Therapy
    • 1.2.4 Immunotherapy
    • 1.2.5 Chemotherapy
    • 1.2.6 Other
  • 1.3 Market by Application
    • 1.3.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hepatocellular Carcinoma
    • 1.3.3 Cholangio Carcinoma
    • 1.3.4 Hepatoblastoma
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Liver Cancer Therapeutics Market Perspective (2017-2028)
  • 2.2 Liver Cancer Therapeutics Growth Trends by Region
    • 2.2.1 Liver Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Liver Cancer Therapeutics Historic Market Size by Region (2017-2022)
    • 2.2.3 Liver Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
  • 2.3 Liver Cancer Therapeutics Market Dynamics
    • 2.3.1 Liver Cancer Therapeutics Industry Trends
    • 2.3.2 Liver Cancer Therapeutics Market Drivers
    • 2.3.3 Liver Cancer Therapeutics Market Challenges
    • 2.3.4 Liver Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Liver Cancer Therapeutics Players by Revenue
    • 3.1.1 Global Top Liver Cancer Therapeutics Players by Revenue (2017-2022)
    • 3.1.2 Global Liver Cancer Therapeutics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Liver Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Liver Cancer Therapeutics Revenue
  • 3.4 Global Liver Cancer Therapeutics Market Concentration Ratio
    • 3.4.1 Global Liver Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Therapeutics Revenue in 2021
  • 3.5 Liver Cancer Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Liver Cancer Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Liver Cancer Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Cancer Therapeutics Breakdown Data by Type

  • 4.1 Global Liver Cancer Therapeutics Historic Market Size by Type (2017-2022)
  • 4.2 Global Liver Cancer Therapeutics Forecasted Market Size by Type (2023-2028)

5 Liver Cancer Therapeutics Breakdown Data by Application

  • 5.1 Global Liver Cancer Therapeutics Historic Market Size by Application (2017-2022)
  • 5.2 Global Liver Cancer Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Liver Cancer Therapeutics Market Size (2017-2028)
  • 6.2 North America Liver Cancer Therapeutics Market Size by Type
    • 6.2.1 North America Liver Cancer Therapeutics Market Size by Type (2017-2022)
    • 6.2.2 North America Liver Cancer Therapeutics Market Size by Type (2023-2028)
    • 6.2.3 North America Liver Cancer Therapeutics Market Share by Type (2017-2028)
  • 6.3 North America Liver Cancer Therapeutics Market Size by Application
    • 6.3.1 North America Liver Cancer Therapeutics Market Size by Application (2017-2022)
    • 6.3.2 North America Liver Cancer Therapeutics Market Size by Application (2023-2028)
    • 6.3.3 North America Liver Cancer Therapeutics Market Share by Application (2017-2028)
  • 6.4 North America Liver Cancer Therapeutics Market Size by Country
    • 6.4.1 North America Liver Cancer Therapeutics Market Size by Country (2017-2022)
    • 6.4.2 North America Liver Cancer Therapeutics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Liver Cancer Therapeutics Market Size (2017-2028)
  • 7.2 Europe Liver Cancer Therapeutics Market Size by Type
    • 7.2.1 Europe Liver Cancer Therapeutics Market Size by Type (2017-2022)
    • 7.2.2 Europe Liver Cancer Therapeutics Market Size by Type (2023-2028)
    • 7.2.3 Europe Liver Cancer Therapeutics Market Share by Type (2017-2028)
  • 7.3 Europe Liver Cancer Therapeutics Market Size by Application
    • 7.3.1 Europe Liver Cancer Therapeutics Market Size by Application (2017-2022)
    • 7.3.2 Europe Liver Cancer Therapeutics Market Size by Application (2023-2028)
    • 7.3.3 Europe Liver Cancer Therapeutics Market Share by Application (2017-2028)
  • 7.4 Europe Liver Cancer Therapeutics Market Size by Country
    • 7.4.1 Europe Liver Cancer Therapeutics Market Size by Country (2017-2022)
    • 7.4.2 Europe Liver Cancer Therapeutics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Liver Cancer Therapeutics Market Size (2017-2028)
  • 8.2 Asia-Pacific Liver Cancer Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Liver Cancer Therapeutics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Liver Cancer Therapeutics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Liver Cancer Therapeutics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Liver Cancer Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Liver Cancer Therapeutics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Liver Cancer Therapeutics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Liver Cancer Therapeutics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Liver Cancer Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Liver Cancer Therapeutics Market Size (2017-2028)
  • 9.2 Latin America Liver Cancer Therapeutics Market Size by Type
    • 9.2.1 Latin America Liver Cancer Therapeutics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Liver Cancer Therapeutics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Liver Cancer Therapeutics Market Share by Type (2017-2028)
  • 9.3 Latin America Liver Cancer Therapeutics Market Size by Application
    • 9.3.1 Latin America Liver Cancer Therapeutics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Liver Cancer Therapeutics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Liver Cancer Therapeutics Market Share by Application (2017-2028)
  • 9.4 Latin America Liver Cancer Therapeutics Market Size by Country
    • 9.4.1 Latin America Liver Cancer Therapeutics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Liver Cancer Therapeutics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Liver Cancer Therapeutics Market Size (2017-2028)
  • 10.2 Middle East & Africa Liver Cancer Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Liver Cancer Therapeutics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Liver Cancer Therapeutics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Liver Cancer Therapeutics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Liver Cancer Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Liver Cancer Therapeutics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Liver Cancer Therapeutics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Liver Cancer Therapeutics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Liver Cancer Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 ArQule
    • 11.1.1 ArQule Company Details
    • 11.1.2 ArQule Business Overview
    • 11.1.3 ArQule Liver Cancer Therapeutics Introduction
    • 11.1.4 ArQule Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.1.5 ArQule Recent Developments
  • 11.2 Bayer
    • 11.2.1 Bayer Company Details
    • 11.2.2 Bayer Business Overview
    • 11.2.3 Bayer Liver Cancer Therapeutics Introduction
    • 11.2.4 Bayer Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.2.5 Bayer Recent Developments
  • 11.3 Bristol-Myers Squibb
    • 11.3.1 Bristol-Myers Squibb Company Details
    • 11.3.2 Bristol-Myers Squibb Business Overview
    • 11.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Introduction
    • 11.3.4 Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.3.5 Bristol-Myers Squibb Recent Developments
  • 11.4 Celsion
    • 11.4.1 Celsion Company Details
    • 11.4.2 Celsion Business Overview
    • 11.4.3 Celsion Liver Cancer Therapeutics Introduction
    • 11.4.4 Celsion Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.4.5 Celsion Recent Developments
  • 11.5 Eisai
    • 11.5.1 Eisai Company Details
    • 11.5.2 Eisai Business Overview
    • 11.5.3 Eisai Liver Cancer Therapeutics Introduction
    • 11.5.4 Eisai Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.5.5 Eisai Recent Developments
  • 11.6 Exelixis
    • 11.6.1 Exelixis Company Details
    • 11.6.2 Exelixis Business Overview
    • 11.6.3 Exelixis Liver Cancer Therapeutics Introduction
    • 11.6.4 Exelixis Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.6.5 Exelixis Recent Developments
  • 11.7 Roche
    • 11.7.1 Roche Company Details
    • 11.7.2 Roche Business Overview
    • 11.7.3 Roche Liver Cancer Therapeutics Introduction
    • 11.7.4 Roche Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.7.5 Roche Recent Developments
  • 11.8 Merck
    • 11.8.1 Merck Company Details
    • 11.8.2 Merck Business Overview
    • 11.8.3 Merck Liver Cancer Therapeutics Introduction
    • 11.8.4 Merck Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.8.5 Merck Recent Developments
  • 11.9 Pfizer
    • 11.9.1 Pfizer Company Details
    • 11.9.2 Pfizer Business Overview
    • 11.9.3 Pfizer Liver Cancer Therapeutics Introduction
    • 11.9.4 Pfizer Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.9.5 Pfizer Recent Developments
  • 11.10 IntegraGen
    • 11.10.1 IntegraGen Company Details
    • 11.10.2 IntegraGen Business Overview
    • 11.10.3 IntegraGen Liver Cancer Therapeutics Introduction
    • 11.10.4 IntegraGen Revenue in Liver Cancer Therapeutics Business (2017-2022)
    • 11.10.5 IntegraGen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer